Mission Viejo-based MYnd Analytics Inc. (Nasdaq: MYND) appointed Patrick Herguth as chief executive officer, replacing George Carpenter who will assume the new role of chief innovation officer.
HEALTHCARE: Big data drives evolution
Big data is the big buzzword in healthcare, and Edwards Lifesciences Corp. (NYSE: EW) is no exception—it’s made it part of a strategy to continue growing one of its three main business lines: critical-care technologies.
FDA Rethinks Device Approval Pathway
Food and Drug Administration approval is only the first step to medical device commercialization; device makers also need to obtain positive insurance coverage decisions from payers.
INNOVATION: Seeks $3M; Kickstarter to get the word out
Irvine-based Bright Buddies Inc. wants to help children with autism and other special needs.
Verrix LLC recently announced the initial close of a Series B funding round for $8 million.
Newport Beach-based Amnion Life, which develops incubation technology for premature babies, is seeking $200,000 on Wefunder to help bring its product to market.
Removes Necessity For Valve Alignment
Edwards Lifesciences Corp. (NYSE: EW) recently won European CE Mark for its next-generation transcatheter valve Sapien 3 Ultra for transcatheter aortic valve replacement.